Impact of obesity on quality of life, psychological status, and disease activity in psoriatic arthritis: a multi‑center study.

Arthritis, Psoriatic / complications C-Reactive Protein / analysis Cross-Sectional Studies Fatigue Humans Obesity / complications Pain Psoriasis Quality of Life / psychology Severity of Illness Index Spondylitis, Ankylosing / psychology Surveys and Questionnaires
Anxiety Depression Disease activity Obesity Psoriatic arthritis Quality of life

Journal

Rheumatology international
ISSN: 1437-160X
Titre abrégé: Rheumatol Int
Pays: Germany
ID NLM: 8206885

Informations de publication

Date de publication:
Apr 2022
Historique:
received: 02 05 2021
accepted: 10 08 2021
pubmed: 29 8 2021
medline: 19 4 2022
entrez: 28 8 2021
Statut: ppublish

Résumé

This article aims to evaluate the possible effect of obesity on quality of life, psychological status, and other clinical variables in Psoriatic arthritis (PsA). PsA patients have been recruited by the Turkish League Against Rheumatism-Network from various centers in Turkey in this cross-sectional study. Patients with a body mass index (BMI) ≥ of 30 kg/m

Identifiants

DOI: 10.1007/s00296-021-04971-8 PMID: 34453579
pubmed: 34453579
doi: 10.1007/s00296-021-04971-8
pii: 10.1007/s00296-021-04971-8
doi:

Substances chimiques

C-Reactive Protein 9007-41-4

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

659-668

Informations de copyright

© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Références

Ritchlin CT, Colbert RA, Gladman DD (2017) Psoriatic arthritis. N Engl J Med 376(10):957–970. https://doi.org/10.1056/NEJMra1505557
doi: 10.1056/NEJMra1505557 pubmed: 28273019 pmcid: 28273019
Queiro R, Lorenzo A, Tejon P, Coto P, Pardo E (2019) Obesity in psoriatic arthritis: comparative prevalence and associated factors. Medicine (Baltimore) 98(28):e16400. https://doi.org/10.1097/MD.0000000000016400
doi: 10.1097/MD.0000000000016400
Solomon DH, Love TJ, Canning C, Schneeweiss S (2010) Risk of diabetes among patients with rheumatoid arthritis, psoriatic arthritis and psoriasis. Ann Rheum Dis 69(12):2114–2117. https://doi.org/10.1136/ard.2009.125476
doi: 10.1136/ard.2009.125476 pubmed: 20584807
Husted JA, Thavaneswaran A, Chandran V, Eder L, Rosen CF, Cook RJ, Gladman DD (2011) Cardiovascular and other comorbidities in patients with psoriatic arthritis: a comparison with patients with psoriasis. Arthritis Care Res 63(12):1729–1735. https://doi.org/10.1002/acr.20627
doi: 10.1002/acr.20627
Perez-Chada LM, Merola JF (2020) Comorbidities associated with psoriatic arthritis: review and update. Clin Immunol (Orlando, Fla) 214:108397. https://doi.org/10.1016/j.clim.2020.108397
doi: 10.1016/j.clim.2020.108397
Gupta S, Syrimi Z, Hughes DM, Zhao SS (2021) Comorbidities in psoriatic arthritis: a systematic review and meta-analysis. Rheumatol Int 41(2):275–284. https://doi.org/10.1007/s00296-020-04775-2
doi: 10.1007/s00296-020-04775-2 pubmed: 33423070 pmcid: 33423070
Bhole VM, Choi HK, Burns LC, Vera Kellet C, Lacaille DV, Gladman DD, Dutz JP (2012) Differences in body mass index among individuals with PsA, psoriasis, RA and the general population. Rheumatology (Oxford) 51(3):552–556. https://doi.org/10.1093/rheumatology/ker349
doi: 10.1093/rheumatology/ker349
Divella R, De Luca R, Abbate I, Naglieri E, Daniele A (2016) Obesity and cancer: the role of adipose tissue and adipo-cytokines-induced chronic inflammation. J Cancer 7(15):2346–2359. https://doi.org/10.7150/jca.16884
doi: 10.7150/jca.16884 pubmed: 27994674 pmcid: 5166547
Van Raemdonck K, Umar S, Szekanecz Z, Zomorrodi RK, Shahrara S (2018) Impact of obesity on autoimmune arthritis and its cardiovascular complications. Autoimmun Rev 17(8):821–835. https://doi.org/10.1016/j.autrev.2018.02.007
doi: 10.1016/j.autrev.2018.02.007 pubmed: 29885537
Porta S, Otero-Losada M, Kölliker Frers RA, Cosentino V, Kerzberg E, Capani F (2020) Adipokines, cardiovascular risk, and therapeutic management in obesity and psoriatic arthritis. Front Immunol 11:590749. https://doi.org/10.3389/fimmu.2020.590749
doi: 10.3389/fimmu.2020.590749 pubmed: 33643281
Love TJ, Zhu Y, Zhang Y, Wall-Burns L, Ogdie A, Gelfand JM, Choi HK (2012) Obesity and the risk of psoriatic arthritis: a population-based study. Ann Rheum Dis 71(8):1273–1277. https://doi.org/10.1136/annrheumdis-2012-201299
doi: 10.1136/annrheumdis-2012-201299 pubmed: 22586165
Li W, Han J, Qureshi AA (2012) Obesity and risk of incident psoriatic arthritis in US women. Ann Rheum Dis 71(8):1267–1272. https://doi.org/10.1136/annrheumdis-2011-201273
doi: 10.1136/annrheumdis-2011-201273 pubmed: 22562978
Azevedo S, Santos-Faria D, Leite Silva J, Ramos Rodrigues J, Sousa Neves J, Peixoto D, Tavares-Costa J, Alcino S, Afonso C, Teixeira F (2019) Obesity, metabolic syndrome and other comorbidities in rheumatoid arthritis and psoriatic arthritis: influence on disease activity and quality of life. Acta Reumatol Portuguesa 44(4):322–324
Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H (2006) Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 54(8):2665–2673. https://doi.org/10.1002/art.21972
doi: 10.1002/art.21972 pubmed: 16871531
McKenna SP, Doward LC, Whalley D, Tennant A, Emery P, Veale DJ (2004) Development of the PsAQoL: a quality of life instrument specific to psoriatic arthritis. Ann Rheum Dis 63(2):162–169. https://doi.org/10.1136/ard.2003.006296
doi: 10.1136/ard.2003.006296 pubmed: 14722205 pmcid: 1754880
Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67(6):361–370. https://doi.org/10.1111/j.1600-0447.1983.tb09716.x
doi: 10.1111/j.1600-0447.1983.tb09716.x pubmed: 6880820 pmcid: 6880820
Schoels M, Aletaha D, Funovits J, Kavanaugh A, Baker D, Smolen JS (2010) Application of the DAREA/DAPSA score for assessment of disease activity in psoriatic arthritis. Ann Rheum Dis 69(8):1441–1447. https://doi.org/10.1136/ard.2009.122259
doi: 10.1136/ard.2009.122259 pubmed: 20525844
Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A (1994) A new approach to defining disease status in ankylosing spondylitis: the bath ankylosing spondylitis disease activity index. J Rheumatol 21(12):2286–2291
pubmed: 7699630
Calin A, Garrett S, Whitelock H, Kennedy LG, O’Hea J, Mallorie P, Jenkinson T (1994) A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 21(12):2281–2285
pubmed: 7699629
Fries JF, Spitz PW, Young DY (1982) The dimensions of health outcomes: the health assessment questionnaire, disability and pain scales. J Rheumatol 9(5):789–793
pubmed: 7175852
Daltroy LH, Larson MG, Roberts NW, Liang MH (1990) A modification of the health assessment questionnaire for the spondyloarthropathies. J Rheumatol 17(7):946–950
pubmed: 2213762
Feldman SR, Fleischer AB Jr, Reboussin DM, Rapp SR, Exum ML, Clark AR, Nurre L (1996) The self-administered psoriasis area and severity index is valid and reliable. J Invest Dermatol 106(1):183–186. https://doi.org/10.1111/1523-1747.ep12329912
doi: 10.1111/1523-1747.ep12329912 pubmed: 8592072
Webster K, Cella D, Yost K (2003) The functional assessment of chronic illness therapy (FACIT) measurement system: properties, applications, and interpretation. Health Qual Life Outcomes 1:79. https://doi.org/10.1186/1477-7525-1-79
doi: 10.1186/1477-7525-1-79 pubmed: 14678568 pmcid: 317391
Coto-Segura P, Eiris-Salvado N, González-Lara L, Queiro-Silva R, Martinez-Camblor P, Maldonado-Seral C, García-García B, Palacios-García L, Gomez-Bernal S, Santos-Juanes J, Coto E (2013) Psoriasis, psoriatic arthritis and type 2 diabetes mellitus: a systematic review and meta-analysis. Br J Dermatol 169(4):783–793. https://doi.org/10.1111/bjd.12473
doi: 10.1111/bjd.12473 pubmed: 23772556
Dubreuil M, Rho YH, Man A, Zhu Y, Zhang Y, Love TJ, Ogdie A, Gelfand JM, Choi HK (2014) Diabetes incidence in psoriatic arthritis, psoriasis and rheumatoid arthritis: a UK population-based cohort study. Rheumatology (Oxford) 53(2):346–352. https://doi.org/10.1093/rheumatology/ket343
doi: 10.1093/rheumatology/ket343
Haroon M, Gallagher P, Heffernan E, FitzGerald O (2014) High prevalence of metabolic syndrome and of insulin resistance in psoriatic arthritis is associated with the severity of underlying disease. J Rheumatol 41(7):1357–1365. https://doi.org/10.3899/jrheum.140021
doi: 10.3899/jrheum.140021 pubmed: 24931949
Ogdie A, Schwartzman S, Husni ME (2015) Recognizing and managing comorbidities in psoriatic arthritis. Curr Opin Rheumatol 27(2):118–126. https://doi.org/10.1097/bor.0000000000000152
doi: 10.1097/bor.0000000000000152 pubmed: 25603040
Loganathan A, Kamalaraj N, El-Haddad C, Pile K (2021) Systematic review and meta-analysis on prevalence of metabolic syndrome in psoriatic arthritis, rheumatoid arthritis and psoriasis. Int J Rheum Dis. https://doi.org/10.1111/1756-185x.14147
doi: 10.1111/1756-185x.14147 pubmed: 34076348
Labitigan M, Bahče-Altuntas A, Kremer JM, Reed G, Greenberg JD, Jordan N, Putterman C, Broder A (2014) Higher rates and clustering of abnormal lipids, obesity, and diabetes mellitus in psoriatic arthritis compared with rheumatoid arthritis. Arthritis Care Res 66(4):600–607. https://doi.org/10.1002/acr.22185
doi: 10.1002/acr.22185
Thomsen RS, Nilsen TIL, Haugeberg G, Gulati AM, Kavanaugh A, Hoff M (2021) Adiposity and physical activity as risk factors for developing psoriatic arthritis: longitudinal data from a population-based study in Norway. Arthritis Care Res 73(3):432–441. https://doi.org/10.1002/acr.24121
doi: 10.1002/acr.24121
Soltani-Arabshahi R, Wong B, Feng BJ, Goldgar DE, Duffin KC, Krueger GG (2010) Obesity in early adulthood as a risk factor for psoriatic arthritis. Arch Dermatol 146(7):721–726. https://doi.org/10.1001/archdermatol.2010.141
doi: 10.1001/archdermatol.2010.141 pubmed: 20644032
Nas K, Kiliç E, Tekeoğlu İ, Keskin Y, Çevik R, Sargin B, Acer Kasman S, Alkan H, Sahin N, Cengiz G, Cüzdan N, Albayrak Gezer İ, Keskin D, Mülkoglu C, Reşorlu H, Ataman Ş, Bal A, Baykul M, Duruöz MT, Küçükakkaş O, Yurdakul OV, Alkan Melikoğlu M, Ayhan FF, Bodur H, Çaliş M, Çapkin E, Devrimsel G, Gök K, Hizmetli S, Kamanlı A, Kocabaş H, Kutluk Ö, Şen N, Şendur ÖF, Toprak M, Tolu S, Tuncer T (2021) The effect of gender on disease activity and clinical characteristics in patients with axial psoriatic arthritis. Mod Rheumatol 31(4):869–874. https://doi.org/10.1080/14397595.2020.1812870
doi: 10.1080/14397595.2020.1812870 pubmed: 32820672
Kalyoncu U, Bayindir Ö, Ferhat Öksüz M, Doğru A, Kimyon G, Tarhan EF, Erden A, Yavuz Ş, Can M, Çetin GY, Kılıç L, Küçükşahin O, Omma A, Ozisler C, Solmaz D, Bozkirli ED, Akyol L, Pehlevan SM, Gunal EK, Arslan F, Yılmazer B, Atakan N, Aydın SZ (2017) The psoriatic arthritis registry of Turkey: results of a multicentre registry on 1081 patients. Rheumatology (Oxford) 56(2):279–286. https://doi.org/10.1093/rheumatology/kew375
doi: 10.1093/rheumatology/kew375
Eder L, Thavaneswaran A, Chandran V, Cook RJ, Gladman DD (2015) Obesity is associated with a lower probability of achieving sustained minimal disease activity state among patients with psoriatic arthritis. Ann Rheum Dis 74(5):813–817. https://doi.org/10.1136/annrheumdis-2013-204448
doi: 10.1136/annrheumdis-2013-204448 pubmed: 24431392
Moroni L, Farina N, Dagna L (2020) Obesity and its role in the management of rheumatoid and psoriatic arthritis. Clin Rheumatol 39(4):1039–1047. https://doi.org/10.1007/s10067-020-04963-2
doi: 10.1007/s10067-020-04963-2 pubmed: 32016655
Kumthekar A, Ogdie A (2020) Obesity and psoriatic arthritis: a narrative review. Rheumatol Ther 7(3):447–456. https://doi.org/10.1007/s40744-020-00215-6
doi: 10.1007/s40744-020-00215-6 pubmed: 32495313 pmcid: 7410935
Klingberg E, Bilberg A, Björkman S, Hedberg M, Jacobsson L, Forsblad-d’Elia H, Carlsten H, Eliasson B, Larsson I (2019) Weight loss improves disease activity in patients with psoriatic arthritis and obesity: an interventional study. Arthritis Res Ther 21(1):17. https://doi.org/10.1186/s13075-019-1810-5
doi: 10.1186/s13075-019-1810-5 pubmed: 30635024 pmcid: 6330463
Ballegaard C, Skougaard M, Guldberg-Møller J, Nissen CV, Amris K, Jørgensen TS, Dreyer L, Kristensen LE (2021) Comorbidities, pain and fatigue in psoriatic arthritis, psoriasis and healthy controls: a clinical cohort study. Rheumatology (Oxford) 60(7):3289–3300. https://doi.org/10.1093/rheumatology/keaa780
doi: 10.1093/rheumatology/keaa780
Michelsen B, Uhlig T, Sexton J, van der Heijde D, Hammer HB, Kristianslund EK, Wierød A, Bakland G, Rødevand E, Krøll F, Loge JH, Haugeberg G, Kvien TK (2018) Health-related quality of life in patients with psoriatic and rheumatoid arthritis: data from the prospective multicentre NOR-DMARD study compared with Norwegian general population controls. Ann Rheum Dis 77(9):1290–1294. https://doi.org/10.1136/annrheumdis-2018-213286
doi: 10.1136/annrheumdis-2018-213286 pubmed: 29875096
Wervers K, Luime JJ, Tchetverikov I, Gerards AH, Kok MR, Appels CWY, van der Graaff WL, van Groenendael J, Korswagen LA, Veris-van Dieren JJ, Hazes JMW, Vis M (2018) Influence of disease manifestations on health-related quality of life in early psoriatic arthritis. J Rheumatol 45(11):1526–1531. https://doi.org/10.3899/jrheum.171406
doi: 10.3899/jrheum.171406 pubmed: 29961685
Azad N, Gondal M, Abbas N (2008) Frequency of depression and anxiety in patients attending a rheumatology clinic. J College Phys Surg Pak: JCPSP 18(9):569–573
Geenen R, Newman S, Bossema ER, Vriezekolk JE, Boelen PA (2012) Psychological interventions for patients with rheumatic diseases and anxiety or depression. Best Pract Res Clin Rheumatol 26(3):305–319. https://doi.org/10.1016/j.berh.2012.05.004
doi: 10.1016/j.berh.2012.05.004 pubmed: 22867928
Husni ME, Merola JF, Davin S (2017) The psychosocial burden of psoriatic arthritis. Semin Arthritis Rheum 47(3):351–360. https://doi.org/10.1016/j.semarthrit.2017.05.010
doi: 10.1016/j.semarthrit.2017.05.010 pubmed: 28802776
Peterson S, Piercy J, Blackburn S, Sullivan E, Karyekar CS, Li N (2019) The multifaceted impact of anxiety and depression on patients with rheumatoid arthritis. BMC Rheumatol 3:43. https://doi.org/10.1186/s41927-019-0092-5
doi: 10.1186/s41927-019-0092-5 pubmed: 31673680 pmcid: 6816159
Bavière W, Deprez X, Houvenagel E, Philippe P, Deken V, Flipo RM, Paccou J (2020) Association between comorbidities and quality of life in psoriatic arthritis: results from a multicentric cross-sectional study. J Rheumatol 47(3):369–376. https://doi.org/10.3899/jrheum.181471
doi: 10.3899/jrheum.181471 pubmed: 31203223
Duruöz MT, Gezer HH, Nas K, Kilic E, Sargin B, Acer Kasman S, Alkan H, Sahin N, Cengiz G, Cuzdan N, Albayrak Gezer İ, Keskin D, Mulkoglu C, Resorlu H, Ataman S, Bal A, Kucukakkas O, Yurdakul OV, Melikoglu MA, Ayhan FF, Baykul M, Bodur H, Calis M, Capkin E, Devrimsel G, Gök K, Hizmetli S, Kamanlı A, Keskin Y, Ecesoy H, Kutluk Ö, Sen N, Sendur ÖF, Tekeoglu İ, Tolu S, Toprak M, Tuncer T (2020) The impact of fatigue on patients with psoriatic arthritis: a multi-center study of the TLAR-network. Rheumatol Int 40(11):1803–1815. https://doi.org/10.1007/s00296-020-04628-y
doi: 10.1007/s00296-020-04628-y pubmed: 32564159
Kotsis K, Voulgari PV, Tsifetaki N, Machado MO, Carvalho AF, Creed F, Drosos AA, Hyphantis T (2012) Anxiety and depressive symptoms and illness perceptions in psoriatic arthritis and associations with physical health-related quality of life. Arthritis Care Res 64(10):1593–1601. https://doi.org/10.1002/acr.21725
doi: 10.1002/acr.21725
McDonough E, Ayearst R, Eder L, Chandran V, Rosen CF, Thavaneswaran A, Gladman DD (2014) Depression and anxiety in psoriatic disease: prevalence and associated factors. J Rheumatol 41(5):887–896. https://doi.org/10.3899/jrheum.130797
doi: 10.3899/jrheum.130797 pubmed: 24692521
Pattison E, Harrison BJ, Griffiths CE, Silman AJ, Bruce IN (2008) Environmental risk factors for the development of psoriatic arthritis: results from a case-control study. Ann Rheum Dis 67(5):672–676. https://doi.org/10.1136/ard.2007.073932
doi: 10.1136/ard.2007.073932 pubmed: 17823200
Højgaard P, Glintborg B, Kristensen LE, Gudbjornsson B, Love TJ, Dreyer L (2016) The influence of obesity on response to tumour necrosis factor-α inhibitors in psoriatic arthritis: results from the DANBIO and ICEBIO registries. Rheumatology (Oxford) 55(12):2191–2199. https://doi.org/10.1093/rheumatology/kew326
doi: 10.1093/rheumatology/kew326
Eder L, Abji F, Rosen CF, Chandran V, Gladman DD (2017) The association between obesity and clinical features of psoriatic arthritis: a case-control study. J Rheumatol 44(4):437–443. https://doi.org/10.3899/jrheum.160532
doi: 10.3899/jrheum.160532 pubmed: 28202737
di Minno MN, Peluso R, Iervolino S, Lupoli R, Russolillo A, Scarpa R, di Minno G (2013) Obesity and the prediction of minimal disease activity: a prospective study in psoriatic arthritis. Arthritis Care Res 65(1):141–147. https://doi.org/10.1002/acr.21711
doi: 10.1002/acr.21711
Scher JU, Ogdie A, Merola JF, Ritchlin C (2019) Preventing psoriatic arthritis: focusing on patients with psoriasis at increased risk of transition. Nat Rev Rheumatol 15(3):153–166. https://doi.org/10.1038/s41584-019-0175-0
doi: 10.1038/s41584-019-0175-0 pubmed: 30742092
George MD, Giles JT, Katz PP, England BR, Mikuls TR, Michaud K, Ogdie-Beatty AR, Ibrahim S, Cannon GW, Caplan L, Sauer BC, Baker JF (2017) Impact of obesity and adiposity on inflammatory markers in patients with rheumatoid arthritis. Arthritis Care Res 69(12):1789–1798. https://doi.org/10.1002/acr.23229
doi: 10.1002/acr.23229

Auteurs

Kevser Gok (K)

Rheumatology Clinic, Ankara City Hospital, Ankara, Turkey. kevserorhangok@gmail.com.
ORCID: 0000-0001-8639-751X

Kemal Nas (K)

Division of Rheumatology and Immunology, Department of Physical Medicine and Rehabilitation, Sakarya University School of Medicine, Sakarya, Turkey.

Ibrahim Tekeoglu (I)

Division of Rheumatology and Immunology, Department of Physical Medicine and Rehabilitation, Sakarya University School of Medicine, Sakarya, Turkey.
ORCID: 0000-0003-3395-7178

Ismihan Sunar (I)

Rheumatology Clinic, Aydın State Hospital, Aydın, Turkey.
ORCID: 0000-0002-4435-5677

Yasar Keskin (Y)

Department of Physical Medicine and Rehabilitation, Bezmiâlem Vakif University, İstanbul, Turkey.
ORCID: 0000-0003-4457-5917

Erkan Kilic (E)

Rheumatology Clinic, Kanuni Training and Research Hospital, Trabzon, Turkey.
ORCID: 0000-0003-4355-4356

Betul Sargin (B)

Division of Rheumatology, Department of Physical Medicine and Rehabilitation, Adnan Menderes University School of Medicine, Aydın, Turkey.
ORCID: 0000-0002-9463-8413

Sevtap Acer Kasman (S)

Division of Rheumatology, Department of Physical Medicine and Rehabilitation, Marmara University School of Medicine, İstanbul, Turkey.
ORCID: 0000-0002-4805-0555

Hakan Alkan (H)

Department of Physical Medicine and Rehabilitation, Pamukkale University School of Medicine, Denizli, Turkey.
ORCID: 0000-0001-8461-9131

Nilay Sahin (N)

Department of Physical Medicine and Rehabilitation, Balıkesir University School of Medicine, Balıkesir, Turkey.
ORCID: 0000-0001-6062-6935

Gizem Cengiz (G)

Division of Rheumatology, Department of Physical Medicine and Rehabilitation, Erciyes University School of Medicine, Kayseri, Turkey.
ORCID: 0000-0002-8143-3048

Nihan Cuzdan (N)

Rheumatology Clinic, Balıkesir Atatürk City Hospital, Balıkesir, Turkey.
ORCID: 0000-0001-7238-657X

İlknur Albayrak Gezer (İ)

Department of Physical Medicine and Rehabilitation, Selçuk University School of Medicine, Konya, Turkey.
ORCID: 0000-0002-8980-1837

Dilek Keskin (D)

Department of Physical Medicine and Rehabilitation, Kırıkkale University School of Medicine, Kırıkkale, Turkey.
ORCID: 0000-0001-5300-6391

Cevriye Mulkoglu (C)

Department of Physical Medicine and Rehabilitation, Ankara Training and Research Hospital, Ankara, Turkey.
ORCID: 0000-0001-9113-3885

Hatice Resorlu (H)

Department of Physical Medicine and Rehabilitation, Çanakkale Onsekiz Mart University School of Medicine, Çanakkale, Turkey.
ORCID: 0000-0001-9889-1064

Ajda Bal (A)

Department of Physical Medicine and Rehabilitation, University of Health Sciences Ankara Dışkapı Yıldırım Beyazıt Training and Research Hospital, Ankara, Turkey.
ORCID: 0000-0002-3910-2851

Mehmet Tuncay Duruoz (MT)

Division of Rheumatology, Department of Physical Medicine and Rehabilitation, Marmara University School of Medicine, İstanbul, Turkey.
ORCID: 0000-0003-3584-2788

Okan Kucukakkas (O)

Department of Physical Medicine and Rehabilitation, Bezmiâlem Vakif University, İstanbul, Turkey.
ORCID: 0000-0001-6971-4229

Ozan Volkan Yurdakul (OV)

Department of Physical Medicine and Rehabilitation, Bezmiâlem Vakif University, İstanbul, Turkey.
ORCID: 0000-0003-4567-8133

Meltem Alkan Melikoglu (M)

Division of Rheumatology, Department of Physical Medicine and Rehabilitation, Atatürk University School of Medicine, Erzurum, Turkey.
ORCID: 0000-0001-7519-9470

Yildiray Aydin (Y)

Department of Physical Medicine and Rehabilitation, Tekirdağ Kapaklı State Hospital, Tekirdağ, Turkey.
ORCID: 0000-0003-4299-5627

Fikriye Figen Ayhan (FF)

Department of Physical Medicine and Rehabilitation, Atilim University Medical School, Ankara, Turkey.
ORCID: 0000-0001-6906-991X

Hatice Bodur (H)

Department of Physical Medicine and Rehabilitation, Yıldırım Beyazıt University School of Medicine, Ankara, Turkey.
ORCID: 0000-0003-3008-7007

Mustafa Calis (M)

Division of Rheumatology, Department of Physical Medicine and Rehabilitation, Erciyes University School of Medicine, Kayseri, Turkey.
ORCID: 0000-0002-1184-0772

Erhan Capkin (E)

Department of Physical Medicine and Rehabilitation, Karadeniz Technical University School of Medicine, Trabzon, Turkey.
ORCID: 0000-0003-2728-5934

Gul Devrimsel (G)

Department of Physical Medicine and Rehabilitation, Recep Tayyip Erdoğan University School of Medicine, Rize, Turkey.
ORCID: 0000-0001-9775-6426

Hilal Ecesoy (H)

Division of Rheumatology, Department of Physical Medicine and Rehabilitation, Necmettin Erbakan University Meram School of Medicine, Konya, Turkey.
ORCID: 0000-0001-9274-168X

Sami Hizmetli (S)

Division of Rheumatology, Department of Physical Medicine and Rehabilitation, Cumhuriyet University School of Medicine, Sivas, Turkey.
ORCID: 0000-0002-0418-0155

Ayhan Kamanli (A)

Division of Rheumatology and Immunology, Department of Physical Medicine and Rehabilitation, Sakarya University School of Medicine, Sakarya, Turkey.
ORCID: 0000-0001-5299-7250

Oznur Kutluk (O)

Rheumatology Clinic, Antalya Training and Research Hospital, Antalya, Turkey.
ORCID: 0000-0003-1037-7381

Nesrin Sen (N)

Rheumatology Clinic, Kartal Dr. Lutfi Kirdar Training and Research Hospital, İstanbul, Turkey.
ORCID: 0000-0003-0966-0075

Omer Faruk Sendur (OF)

Department of Physical Medicine and Rehabilitation and Algology, Medicana International Hospital, İzmir, Turkey.
ORCID: 0000-0002-0718-9438

Sena Tolu (S)

Department of Physical Medicine and Rehabilitation, Medipol University School of Medicine, Istanbul, Turkey.
ORCID: 0000-0002-1111-3110

Murat Toprak (M)

Department of Physical Medicine and Rehabilitation, Yuzuncu Yıl University School of Medicine, Van, Turkey.
ORCID: 0000-0002-6490-4645

Tiraje Tuncer (T)

Division of Rheumatology, Department of Physical Medicine and Rehabilitation, Akdeniz University School of Medicine, Antalya, Turkey.
ORCID: 0000-0001-8654-0603

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Maladies de la peau et du tissu conjonctif › Maladies de la peau › Dermatoses papulosquameuses › Psoriasis › Arthrite psoriasique › Impact of obesity on quality of life,...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines du sang › Immunoprotéines › Protéine C-réactive › Impact of obesity on quality of life,...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Caractéristiques des études épidémiologiques › Études épidémiologiques › Études transversales › Impact of obesity on quality of life,...
questionsmedicales.fr › États, signes et symptômes pathologiques › Signes et symptômes › Fatigue › Impact of obesity on quality of life,...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Impact of obesity on quality of life,...
questionsmedicales.fr › États, signes et symptômes pathologiques › Signes et symptômes › Obésité › Impact of obesity on quality of life,...
questionsmedicales.fr › Phénomènes physiologiques de l'appareil locomoteur et du système nerveux › Phénomènes physiologiques du système nerveux › Sensation › Douleur › Impact of obesity on quality of life,...
questionsmedicales.fr › Maladies de la peau et du tissu conjonctif › Maladies de la peau › Dermatoses papulosquameuses › Psoriasis › Impact of obesity on quality of life,...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Mesures épidémiologiques › Démographie › État de santé › Qualité de vie › Impact of obesity on quality of life,...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Collecte de données › Enquêtes et questionnaires › Enquêtes de santé › Indicateurs d'état de santé › Acuité des besoins du patient › Indice de gravité de la maladie › Impact of obesity on quality of life,...
questionsmedicales.fr › Maladies ostéomusculaires › Maladies articulaires › Arthrite › Spondylarthrite › Spondylarthropathies › Spondyloarthrite axiale › Pelvispondylite rhumatismale › Impact of obesity on quality of life,...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Collecte de données › Enquêtes et questionnaires › Impact of obesity on quality of life,...